Integrated Multi‐Omics Analysis Elucidates the Metabolic Basis of Enhanced Echinocandin B Biosynthesis and Guides Targeted Engineering in Aspergillus nidulans
Biotechnology Journal · 2026
DOI: 10.1002/biot.70217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2026. Verfasst von Xiaozhang Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: National and Local Joint Engineering Research Center for Biomanufacturing of Chiral Chemicals, Zhejiang University of Technology, Hangzhou, P.R. Chin…. Hauptthemen laut MEDLINE: Aspergillus nidulans, Echinocandins, Metabolic Engineering. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Echinocandin B (ECB) serves as a crucial precursor for the antifungal drug anidulafungin, yet its production cost remains high due to low fermentation titers. We previously screened a highly efficient ECB producer Aspergillus nidulans ZJB16068, but its further metabolic engineering is hindered by unclear physiological and regulatory mechanisms responsible for high production. To address this, we conducted time‐resolved transcriptomic and proteomic analyses across three fermentation phases (days 4, 7, and 10). Our results reveal that during the transition from growth to production, primary metabolism is systematically downregulated, while pathways supplying precursor amino acids (L‐Thr, L‐Pro, L‐Orn) are upregulated in the later production phase. Notably, acetyl‐CoA flux is redirected toward secondary metabolism through citrate synthase downregulation, accompanied by enhanced NADPH generation via the pentose phosphate pathway to support the heightened demand for reducing power. Unexpectedly, ECB biosynthetic genes are not induced, whereas the competing sterigmatocystin pathway acts as a major acetyl‐CoA sink. Further analysis identified limited fatty acid β ‐oxidation as a constraint on acetyl‐CoA availability. Overexpression of β ‐oxidation genes ( FOX1 , FOX2 , POT1 ) increased ECB titers by 25.1%–33.5%. This study delineates the physiological phenotype underlying high ECB production and demonstrates how multi‐omics‐driven target identification guides effective metabolic engineering for strain enhancement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National and Local Joint Engineering Research Center for Biomanufacturing of Chiral Chemicals, Zhejiang University of Technology, Hangzhou, P.R. China.
- Zhejiang Tiantai Pharmaceutical Co., Ltd, Taizhou City, Zhejiang, P.R. China.
- Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, P.R. China.
ORCID-Profile: Zhi-Qiang Liu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Yang, X., Pang, A. P., Chen, H. L., Kou, T., Zhang, Y. H., Huang, L., Liu, Z. Q., & Zheng, Y. G. (2026). Integrated Multi‐Omics Analysis Elucidates the Metabolic Basis of Enhanced Echinocandin B Biosynthesis and Guides Targeted Engineering in Aspergillus nidulans. Biotechnology Journal. https://doi.org/10.1002/biot.70217
Vancouver
Yang X, Pang AP, Chen HL, Kou T, Zhang YH, Huang L, et al. Integrated Multi‐Omics Analysis Elucidates the Metabolic Basis of Enhanced Echinocandin B Biosynthesis and Guides Targeted Engineering in Aspergillus nidulans. Biotechnology Journal. 2026. doi:10.1002/biot.70217
BibTeX
@article{Yang2026,
author = {Yang, Xiaozhang and Pang, Ai-Ping and Chen, Hui-Ling and Kou, Tong and Zhang, Yi-Hang and Huang, Lianggang and Liu, Zhi-Qiang and Zheng, Yu-Guo},
title = {Integrated Multi‐Omics Analysis Elucidates the Metabolic Basis of Enhanced Echinocandin B Biosynthesis and Guides Targeted Engineering in Aspergillus nidulans},
journal = {Biotechnology Journal},
year = {2026},
doi = {10.1002/biot.70217}
}
EUVIMED